{"id":154140,"date":"2014-10-27T05:55:10","date_gmt":"2014-10-27T09:55:10","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/scleroderma-patients-seek-experimental-u-s-stem-cell-therapy.php"},"modified":"2014-10-27T05:55:10","modified_gmt":"2014-10-27T09:55:10","slug":"scleroderma-patients-seek-experimental-u-s-stem-cell-therapy","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/scleroderma-patients-seek-experimental-u-s-stem-cell-therapy.php","title":{"rendered":"Scleroderma patients seek experimental U.S. stem cell therapy"},"content":{"rendered":"<p><p>    CTVNews.ca Staff  Published Saturday, October 25, 2014 10:30PM  EDT  Last Updated Saturday, October 25, 2014  11:46PM EDT<\/p>\n<p>    An estimated 16,000 Canadians live with scleroderma, an    incurable autoimmune disorder which causes the body to produce    too much collagen, resulting in a hardening of the skin and    tissue. There is no cure for the scleroderma, but some patients    in Canada are now seeking a costly and experimental stem cell    therapy in the U.S.  <\/p>\n<p>    A little over a year ago, Mike Berry of Kingston, Ont., started    having trouble breathing. It was the first sign of scleroderma.  <\/p>\n<p>    Berry, 42, suffers from the systemic version of scleroderma,    which attacks his internal organs. His lungs have been scarred    by the disorder, with his lung capacity dropping to 41 per cent    in just nine months. His disease may ultimately be fatal.  <\/p>\n<p>    He described to CTV News how scleroderma has impacted his    day-to-day life.  <\/p>\n<p>    \"I'm unable to work any longer; it affects me and everything    now,\" he said. \"It's hard to walk fast; I can't walk and talk.\"  <\/p>\n<p>    Drugs to treat his scleroderma haven't worked, so now Berry is    trying to fundraise more than $150,000 for an experimental    U.S. stem cell treatment called Autologous Hematopoietic Stem    Cell Transplantation (HSCT), in the hopes that it will save his    life.  <\/p>\n<p>    \"It would give me as second chance, I guess I just have a lot    to fight for,\" he said.  <\/p>\n<p>    Pioneered by Dr. Richard Burt at Northwestern Memorial Hospital    in Chicago, patients receiving HSCT are administered stem cells    intravenously.  <\/p>\n<p>    During the treatment, the patient's stem cells are harvested,    and then the patient's over-active immune system is destroyed    with powerful chemotherapy drugs. Doctors then re-program the    patient's immune system with the harvested stem cells, in the    hopes that the cells will \"reset\" the patient's immune system    and stop scleroderma.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.ctvnews.ca\/health\/scleroderma-patients-seek-experimental-u-s-stem-cell-therapy-1.2071491\/RK=0\/RS=ovx.RzhHQ0R4DZZIUZQphGg6_z4-\" title=\"Scleroderma patients seek experimental U.S. stem cell therapy\">Scleroderma patients seek experimental U.S. stem cell therapy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> CTVNews.ca Staff Published Saturday, October 25, 2014 10:30PM EDT Last Updated Saturday, October 25, 2014 11:46PM EDT An estimated 16,000 Canadians live with scleroderma, an incurable autoimmune disorder which causes the body to produce too much collagen, resulting in a hardening of the skin and tissue. There is no cure for the scleroderma, but some patients in Canada are now seeking a costly and experimental stem cell therapy in the U.S. A little over a year ago, Mike Berry of Kingston, Ont., started having trouble breathing.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/scleroderma-patients-seek-experimental-u-s-stem-cell-therapy.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-154140","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/154140"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=154140"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/154140\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=154140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=154140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=154140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}